David Emerson Jorden insider trades

Open-market stock purchases and sales by David Emerson Jorden, CEO/CFO at Nuo Therapeutics, Inc, from SEC Form 4 filings since Apr 9, 2010.

Recent trades

DateStockTradeValue
Jun 5, 2026AURX Nuo Therapeutics, IncBought (not open market)$14.5K
Jan 1, 2026AURX Nuo Therapeutics, IncBought (not open market)$50K
Jan 1, 2026AURX Nuo Therapeutics, IncSold (not open market)$50K
Nov 28, 2025AURX Nuo Therapeutics, IncSold$300K

Companies traded

  • AURX Nuo Therapeutics, Inc: 1 buy, 8 sales, last Jun 5, 2026
  • PLXP PLx Pharma Inc: 1 buy, last Jun 14, 2017
  • NONE Nuo Therapeutics, Inc: 1 buy, last Jan 9, 2017
  • NUOT Nuo Therapeutics, Inc: other filings, last Jul 9, 2015
  • OPXA Opexa Therapeutics, Inc: 2 buys, last Sep 24, 2013
  • CMXI Cytomedix Inc: 37 buys, 3 sales, last May 21, 2013
  • CMXI.OB Cytomedix Inc: other filings, last Dec 1, 2011
  • GTF Cytomedix Inc: 48 buys, last Jan 25, 2011
  • CTF Cytomedix Inc: 1 buy, last Jun 8, 2010

Get free alerts when David Emerson Jorden files a new trade →